Biocartis Awarded $2.3M Grant to Build Out MDx Platform | GenomeWeb

NEW YORK (GenomeWeb) – The Flemish Government has awarded Biocartis a €1.7 million ($2.3 million) grant to build out the capabilities of the company's Idylla molecular diagnostics platform, Biocartis said today.

Biocartis said it will use the funding to further develop its hybrid multiplexing technology to detect and quantify multiple biomarker types on single Idylla tests. The company has developed oncology assays that can already detect tens of biomarkers of the same type.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.